Amarin Corp Plcuk (AMRN) Operating Leases (2019 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Operating Leases of $7.7 million for Q1 2026, down 25.24% YoY from $10.3 million in Q1 2025, and down 6.1% sequentially from $8.2 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Operating Leases (2019 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Operating Leases across 8 years of filings, most recently posting $7.7 million for Q1 2026.
- In Q1 2026, Operating Leases fell 25.24% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (down 25.24% YoY), while the FY2025 annual figure was $8.2 million, up 6.18% from the prior year.
- Operating Leases declined to $7.7 million in Q1 2026, from $8.2 million in the prior quarter.
- Over the last five years, Operating Leases for AMRN reached as high as $11.7 million in Q1 2023 and fell as low as $6.7 million in Q3 2025.
- The 5-year median for Operating Leases is $9.7 million (2024), against an average of $9.5 million.
- Annual changes were most pronounced in 2022 — Operating Leases climbed 25.35% — and 2025, when it plunged 34.01%.
- A 5-year view of Operating Leases shows it stood at $10.0 million in 2022, then climbed by 5.84% to $10.6 million in 2023, then declined by 27.14% to $7.7 million in 2024, then gained by 6.18% to $8.2 million in 2025, then fell by 6.1% to $7.7 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $7.7 million, $8.2 million, and $6.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 8.20 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 10.30 Mn |
| Dec 31, 2024 | 7.72 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | 8.39 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Sep 30, 2023 | 8.97 Mn |
| Jun 30, 2023 | 9.47 Mn |
| Mar 31, 2023 | 11.70 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 10.17 Mn |
| Mar 31, 2022 | 11.30 Mn |
| Dec 31, 2021 | 8.58 Mn |
| Sep 30, 2021 | 10.50 Mn |
| Jun 30, 2021 | 10.50 Mn |